ASSOCIATION OF THE MMP7 –181A>G PROMOTER
POLYMORPHISM WITH EARLY ONSET OF
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Tacheva T1,*, Dimov D2, Anastasov A1, Zhelyazkova Y2,
Kurzawski M3, Gulubova M4, Drozdzik M3, Vlaykova T1
*Corresponding Author: Assistant Professor Tanya Tacheva, Department of Chemistry and Biochemistry, Medical Faculty,
Trakia University, 11 Armeiska Str., Stara Zagora, Bulgaria. Tel: +359878334176. E-mail: tanya.ta4eva@abv.bg
page: 59
|
|
REFERENCES
1. GOLD 2017. Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary
disease 2017 report. [Available from http://
gold copd.org/gold-2017-global-strategy-diagnosismanagement-
prevention-copd/.]
2. Echave-Sustaeta JM, Comeche Casanova L, Cosio
BG, Soler-Cataluna JJ, Garcia-Lujan R, Ribera X.
Comor-bidity in chronic obstructive pulmonary disease.
Related to disease severity? Int J Chron Obstruct
Pulmon Dis. 2014; 9: 1307-1314.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA,
Calverley P, et al. Global strategy for the diagnosis,
management, and prevention of chronic obstructive
pul-monary disease: GOLD executive summary. Am
J Respir Crit Care Med. 2007; 176(6): 532-555.
4. Hogg JC. Pathophysiology of airflow limitation in
chronic obstructive pulmonary disease. Lancet. 2004;
364(9435): 709-721.
5. Parks WC. Matrix metalloproteinases in lung repair.
Eur Respir J Suppl. 2003; 44: 36s-8s.
6. Gharib SA, Altemeier WA, Van Winkle LS, Plopper
CG, Schlesinger SY, Buell CA, et al. Matrix metallo-
proteinase-7 coordinates airway epithelial injury
response and differentiation of ciliated cells. Am J
Respir Cell Mol Biol. 2013; 48(3): 390-396.
7. McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-
7) mediates E-cadherin ectodomain
shedding in injured lung epithelium. Am J Pathol.
2003; 162(6): 1831-1843. 8. Vandenbroucke RE, Dejonckheere E, Libert C. A therapeutic
role for matrix metalloproteinase inhibitors in
lung diseases? Eur Respir J. 2011; 38(5): 1200-1214.
9. McCawley LJ, Matrisian LM. Matrix metallo-proteinases:
They’re not just for matrix anymore! Curr
Opin Cell Biol. 2001; 13(5): 534-540.
10. Visse R, Nagase H. Matrix metalloproteinases and
tissue inhibitors of metalloproteinases: Structure, function,
and biochemistry. Circ Res. 2003; 92(8): 827-839.
11. Han JC, Li XD, Du J, Xu F, Wei YJ, Li HB, et al.
Elevated matrix metalloproteinase-7 expression promotes
metastasis in human lung carcinoma. World J
Surg Oncol. 2015; 13(5): 1477-7819.
12. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson
CL, Matrisian LM, Welgus HG, et al. Matrilysin expression
and function in airway epithelium. J Clin
Invest. 1998; 102(7): 1321-1331.
13. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin
shedding of syndecan-1 regulates chemokine mobilization
and transepithelial efflux of neutrophils in
acute lung injury. Cell. 2002; 111(5): 635-646.
14. Manicone AM, Huizar I, McGuire JK. Matrilysin
(matrix metalloproteinase-7) regulates anti-inflammatory
and antifibrotic pulmonary dendritic cells that
express CD103 (αEβ7-integrin). Am J Pathol. 2009;
175(6): 2319-2331.
15. Jormsjo S, Whatling C, Walter DH, Zeiher AM,
Hamsten A, Eriksson P. Allele-specific regulation
of matrix metalloproteinase-7 promoter activity is
associated with coronary artery luminal dimensions
among hyper-cholesterolemic patients. Arterioscler
Thromb Vasc Biol. 2001; 21(11): 1834-1839.
16. Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai
H, et al. Genetic polymorphisms in the MMP-7 gene
and breast cancer survival. Int J Cancer. 2009; 124(1):
208-214.
17. Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y. Association
between polymorphisms in the promoter regions
of matrix metalloproteinases (MMPs) and risk
of cancer metastasis: A meta-analysis. PLoS One.
2012;7(2):14.
18. Scherf DB, Dally H, Muller P, Werle-Schneider G,
Jager B, Edler L, et al. Single nucleotide polymorphisms
in matrix metalloproteinase genes and lung
cancer chemo-therapy response and prognosis. Eur
Respir J. 2010; 35(2): 381-390.
19. Ji X, Wang L, Wu B, Han R, Han L, Wang T, et al.
Associations of MMP1, MMP2 and MMP3 genes
polymorphism with coal workers’ pneumoconiosis
in Chinese Han Population. Int J Environ Res Public
Health. 2015; 12(11): 13901-13912.
20. Kastelijn EA, van Moorsel CH, Ruven HJ, Karthaus
V, Kwakkel-van Erp JM, van de Graaf EA, et al.
Genetic polymorphisms in MMP7 and reduced serum
levels associate with the development of bronchiolitis
obliterans syndrome after lung transplantation. J
Heart Lung Transplant. 2010; 29(6):680-686.
21. Richards TJ, Park C, Chen Y, Gibson KF, Peter Di Y,
Pardo A, et al. Allele-specific transactivation of matrix
metalloproteinase 7 by FOXA2 and correlation
with plasma levels in idiopathic pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2012; 302(8):
L746-L754.
22. Montano M, Sansores RH, Becerril C, Cisneros J,
Gonzalez-Avila G, Sommer B, et al. FEV1 inversely
correlates with metalloproteinases 1, 7, 9 and CRP
in COPD by biomass smoke exposure. Respir Res.
2014; 15: 74. doi: 1186/1465-9921-15-74.
23. Mogulkoc U, Coskunpinar E, Aynaci E, Caglar E,
Ortakoylu MG, Ozkan G, et al. Is MMP-7 gene polymor-
phism a possible risk factor for chronic obstructive
pul-monary disease in Turkish patients. Genet
Test Mol Biomarkers. 2012; 16(6): 519-523.
24. Preacher KJ. Calculation for the χ2 test: An interactive
calculation too for χ2 tests of goodness of fit and
independence [Computer software]. 2001. [Available
from http://www.quantpsy.org/.]
25. Demedts IK, Brusselle GG, Bracke KR, Vermaelen
KY, Pauwels RA. Matrix metalloproteinases in asthma
and COPD. Curr Opin Pharmacol. 2005; 5(3):
257-263.
26. Lu L, Gunja-Smith Z, Woessner JF, Ursell PC, Nissen
T, Galardy RE, et al. Matrix metalloproteinases
and collagen ultrastructure in moderate myocardial
ischemia and reperfusion in vivo. Am J Physiol Heart
Circ Physiol. 2000; 279(2): H601-H609.
27. Yoon HK, Cho HY, Kleeberger SR. Protective role
of matrix metalloproteinase-9 in ozone-induced airway
inflammation. Environ Health Perspect. 2007;
115(11): 1557-1563.
28. Kofla-Dlubacz A, Matusiewicz M, Krzystek-Korpacka
M, Iwanczak B. Correlation of MMP-3 and
MMP-9 with Crohn’s disease activity in children.
Dig Dis Sci. 2012; 57(3): 706-712.
29. Brajer B, Batura-Gabryel H, Nowicka A, Kuznar-
Kaminska B, Szczepanik A. Concentration of matrix metalloproteinase-9 in serum of patients with chronic
obstructive pulmonary disease and a degree of airway
obstruction and disease progression. J Physiol
Pharmacol. 2008; 59(Suppl 6): 145-152.
30. Ostridge K, Williams N, Kim V, Harden S, Bourne
S, Coombs NA, et al. Distinct emphysema subtypes
defined by quantitative CT analysis are associated
with specific pulmonary matrix metalloproteinases.
Respir Res. 2016; 17(1): 92. doi: 1186/s12931-016-
0402-z.
31. Manjari KS, Jyothy A, Kumar PS, Prabhakar B, Nallari
P, Venkateshwari A. Association of matrix metalloproteinase-
7 (-181A/G) promoter polymorphism in
chronic pancreatitis. Indian J Med Res. 2014; 140(5):
609-615.
32. Belaaouaj AA, Li A, Wun TC, Welgus HG, Shapiro
SD. Matrix metalloproteinases cleave tissue factor
pathway inhibitor. Effects on coagulation. J Biol
Chem. 2000; 275(35): 27123-27128.
|
|
|
|
 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
